BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 18, 2006
View Archived Issues
Threshold Dives On Lack Of Efficacy In BPH Trials
Shares of Threshold Pharmaceuticals Inc. lost more than half their value after the company said it was dropping its benign prostatic hyperplasia drug, TH-070, following misses in Phase II and Phase III studies. (BioWorld Today)
Read More
Actelion, Roche Sign $630M Autoimmunity Product Deal
Read More
Senate Scheduled To Take Vote Today On Pivotal ESC
Read More
Tigris Licenses Aminoflavone Prodrug For Cancer From NIH
Read More
Concert Pharma Brings In $10M Via Series A Round
Read More
Clinic Roundup
Read More
Other News To Note
Read More